Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | KNSA | VKTX | ||
| Company | Eidos Therapeutics Inc | Kiniksa Pharmaceuticals International Plc | Viking Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 63.43 | 38.01 | ||
| High | 128.49 | 63.64 | 38.70 | ||
| Low | 116.83 | 60.89 | 37.11 | ||
| Latest | 122.21 | 60.94 | 38.12 | ||
| Change | -6.23 | -2.50 | -0.74 | ||
| % Change | -4.85% | -3.94% | -1.90% | ||
| Volume | 335,500 | 586,000 | 2,006,600 | ||
| 20-Day Average Volume | 113,985 | 1,063,875 | 2,978,435 | ||
| Previous Close | 128.44 | 63.44 | 38.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 59.80 | 36.06 | ||
| 20-Day Raw Stochastic | 36.63% | 59.95% | 67.34% | ||
| 20-Day Relative Strength | 56.42 | 56.13 | 57.38 | ||
| Weighted Alpha | +136.62 | +87.64 | +37.99 | ||
| Today's Opinion | 88% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | -2.92% since 07/06/26 | -1.52% since 07/06/26 | ||
| Low | 116.83 on 01/25/21 | 60.89 on 07/13/26 | 37.11 on 07/13/26 | ||
| High | 131.08 on 01/20/21 | 67.53 on 07/07/26 | 42.79 on 07/07/26 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +17.44% since 06/12/26 | +32.59% since 06/12/26 | ||
| Low | 116.24 on 01/05/21 | 51.08 on 06/16/26 | 29.00 on 06/16/26 | ||
| High | 132.54 on 01/04/21 | 67.53 on 07/07/26 | 42.79 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +28.84% since 04/13/26 | +8.88% since 04/13/26 | ||
| Low | 69.38 on 10/30/20 | 41.49 on 04/21/26 | 27.16 on 06/11/26 | ||
| High | 132.54 on 01/04/21 | 67.53 on 07/07/26 | 42.79 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +57.88% since 01/13/26 | +24.21% since 01/13/26 | ||
| Low | 38.44 on 07/31/20 | 37.02 on 01/15/26 | 25.77 on 02/05/26 | ||
| High | 132.54 on 01/04/21 | 67.53 on 07/07/26 | 42.79 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,880,947 | 4,511,880 | ||
| Shares Outstanding, K | 38,873 | 76,938 | 116,106 | ||
| Annual Sales | 26,690,000 | 677,560,000 | 0 | ||
| Annual Net Income | -37,840,000 | 59,010,000 | -359,640,000 | ||
| Last Quarter Sales | 130,000 | 214,270,000 | 0 | ||
| Last Quarter Net Income | -30,180,000 | 22,590,000 | -158,330,000 | ||
| 60-Month Beta | -0.16 | 0.07 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.27 on 04/28/26 | -1.37 on 04/29/26 | ||
| Earnings Date | 02/24/21 | 08/04/26 | 07/22/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 72.64 | 0.00 | ||